Citation

Lawrence J. Pharm. J. 2016; 297(7891): 24-27.

Copyright

(Copyright © 2016, Pharmaceutical Press)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; cognition; suicide; physical activity; neutropenia; placebo; rheumatoid arthritis; lymphoma; intravenous drug administration; chronic fatigue syndrome; drug hypersensitivity; gamma interferon; cytomegalovirus infection; kinesiotherapy; Article; cyclophosphamide; Human herpesvirus 6; mononucleosis; neurasthenia; Cytomegalovirus; rituximab; antiviral therapy; Epstein Barr virus; valganciclovir; phase 2 clinical trial (topic); cognitive behavioral therapy; physiotherapist; graded exercise therapy; herpes virus infection; virus etiology